An open-label, randomized, cross-over bioequivalence study of montelukast 10 mg tablets in healthy Thai volunteers
To determine bioequivalence of a generic 10 mg montelukast tablet formulation. A 2-period, 2- sequence crossover study was designed. It included 28 healthy subjects, each subject received a single dose of the randomly assigned formulation with 240 ml water after 10-hr fasting, and 14 blood samples...
Main Authors: | Chaveewan Ratanajamit, Bodin Khwannimit, Kiticha Chotephinyononte |
---|---|
Format: | Article |
Language: | English |
Published: |
Prince of Songkla University
2017-06-01
|
Series: | Songklanakarin Journal of Science and Technology (SJST) |
Subjects: | |
Online Access: | http://rdo.psu.ac.th/sjstweb/journal/39-3/39-3-7.pdf |
Similar Items
-
Cysteine leukotrienes as key mediators of immune-dependent diseases and the therapeutic potential of the leukotriene receptor antagonist (montelukast). Part 2
by: N. G. Astafieva, et al.
Published: (2024-05-01) -
Cysteine leukotrienes as key mediators of immune-dependent diseases and the therapeutic potential of the leukotriene receptor antagonist (montelukast). Part 1
by: N. G. Astafieva, et al.
Published: (2024-04-01) -
Montelukast As An Add On Therapy In Asthma As Compared To Its Use In Asthma Associated With Concomitant Rhinitis Symptoms
by: kassim M. Sultan
Published: (2011-07-01) -
Evaluation of Neuropsychiatric Effects of Montelukast–Levocetirizine Combination Therapy in Children with Asthma and Allergic Rhinitis
by: Uğur Altaş, et al.
Published: (2023-07-01) -
Meta-analysis of the relationship between montelukast use and neuropsychiatric events in patients with allergic airway disease
by: Yakui Mou, et al.
Published: (2023-11-01)